In New Suit, MIT, E8 Claim Navigenics' Purchase of Affy's CLIA Lab Infringes Genotyping Patent | GenomeWeb

NEW YORK (GenomeWeb News) - The Massachusetts Institute of Technology and MIT spinout E8 Pharmaceuticals have filed a lawsuit against Navigenics that alleges the consumer genomics firm is infringing a genotyping patent that was issued to MIT and licensed to E8.

The suit is the second that MIT and E8 have filed regarding US Patent No. 6,703,228, "Methods and products related to genotyping and DNA analysis," which was issued in 2004 and covers the use of SNPs to perform high-throughput genome scans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.